TGF-β neutralization attenuates tumor residency of activated T cells to enhance systemic immunity in mice

<p>Deep TCR sequencing was performed using the TCR Profiling Kit from MiLaboratories (Mouse &alpha;/&beta; TCR RNA; Kit MiLaboratories; TMMR-001). Deep TCR sequencing was analyzed using the MiXCR software from MiLaboratories per manufacturer's recommendations. The files correspond to the TCR-beta sequences.<br>The files are named as follows:</p> <p>&nbsp;</p> <table> <tbody> <tr> <td>file_name</td> <td>cell type sequenced</td> <td>tissue of origin</td> <td>treatment</td> <td>mouse_id</td> </tr> <tr> <td>21BA1dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>bintrafusp alpha</td> <td>1</td> </tr> <tr> <td>23BA2dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>bintrafusp alpha</td> <td>2</td> </tr> <tr> <td>25BA3dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>bintrafusp alpha</td> <td>3</td> </tr> <tr> <td>27BA4dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>bintrafusp alpha</td> <td>4</td> </tr> <tr> <td>29BA5dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>bintrafusp alpha</td> <td>5</td> </tr> <tr> <td>22BA1SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>bintrafusp alpha</td> <td>1</td> </tr> <tr> <td>24BA2SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>bintrafusp alpha</td> <td>2</td> </tr> <tr> <td>26BA3SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>bintrafusp alpha</td> <td>3</td> </tr> <tr> <td>28BA4SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>bintrafusp alpha</td> <td>4</td> </tr> <tr> <td>30BA5SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>bintrafusp alpha</td> <td>5</td> </tr> <tr> <td>31CON1dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>control</td> <td>6</td> </tr> <tr> <td>33CON2dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>control</td> <td>7</td> </tr> <tr> <td>35CON3dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>control</td> <td>8</td> </tr> <tr> <td>37CON4dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>control</td> <td>9</td> </tr> <tr> <td>39CON5dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>control</td> <td>10</td> </tr> <tr> <td>32CON1SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>control</td> <td>6</td> </tr> <tr> <td>34CON2SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>control</td> <td>7</td> </tr> <tr> <td>36CON3SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>control</td> <td>8</td> </tr> <tr> <td>38CON4SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>control</td> <td>9</td> </tr> <tr> <td>40CON5SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>control</td> <td>10</td> </tr> <tr> <td>1aPDL11dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>anti-PDL1 antibody</td> <td>11</td> </tr> <tr> <td>3aPDL12dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>anti-PDL1 antibody</td> <td>12</td> </tr> <tr> <td>5aPDL13dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>anti-PDL1 antibody</td> <td>13</td> </tr> <tr> <td>7aPDL14dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>anti-PDL1 antibody</td> <td>14</td> </tr> <tr> <td>9aPDL15dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>anti-PDL1 antibody</td> <td>15</td> </tr> <tr> <td>2aPDL11SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>anti-PDL1 antibody</td> <td>11</td> </tr> <tr> <td>4aPDL12SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>anti-PDL1 antibody</td> <td>12</td> </tr> <tr> <td>6aPDL13SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>anti-PDL1 antibody</td> <td>13</td> </tr> <tr> <td>8aPDL14SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>anti-PDL1 antibody</td> <td>14</td> </tr> <tr> <td>10aPDL15SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>anti-PDL1 antibody</td> <td>15</td> </tr> <tr> <td>11aTGFB1dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>anti-TGF-beta antibody</td> <td>16</td> </tr> <tr> <td>13aTGFB2dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>anti-TGF-beta antibody</td> <td>17</td> </tr> <tr> <td>15aTGFB3dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>anti-TGF-beta antibody</td> <td>18</td> </tr> <tr> <td>17aTGFB4dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>anti-TGF-beta antibody</td> <td>19</td> </tr> <tr> <td>19aTGFB5dLN.clones_TRB.tsv</td> <td>T cells</td> <td>tumor-draining lymph node</td> <td>anti-TGF-beta antibody</td> <td>20</td> </tr> <tr> <td>12aTGFB1SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>anti-TGF-beta antibody</td> <td>16</td> </tr> <tr> <td>14aTGFB2SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>anti-TGF-beta antibody</td> <td>17</td> </tr> <tr> <td>16aTGFB3SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>anti-TGF-beta antibody</td> <td>18</td> </tr> <tr> <td>18aTGFB4SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>anti-TGF-beta antibody</td> <td>19</td> </tr> <tr> <td>20aTGFB5SP.clones_TRB.tsv</td> <td>T cells</td> <td>spleen</td> <td>anti-TGF-beta antibody</td> <td>20</td> </tr> </tbody> </table>